Emcure Pharmaceuticals Ltd Subsidiary Acquires Cutimed Inc. for CAD $ 5.05 Million
Emcure Pharmaceuticals Ltd announced that its step-down subsidiary, Mantra Pharma Inc., has entered into a share purchase agreement to acquire 100% of the issued and outstanding shares of Cutimed Inc., a company incorporated under the laws of Canada. Cutimed is engaged in cosmetics and personal care products, including dermatological creams and cleanser products. The acquisition, which was completed on April 01, 2026 (EDT), will strengthen Emcure's portfolio in the Canadian dermatological and cosmetic product segments and support its long-term growth strategy. The transaction is aligned with the core business of the Group and is subject to completion of requisite compliances in accordance with applicable laws in Canada and customary conditions.
Key Highlights
- Emcure Pharmaceuticals Ltd's step-down subsidiary, Mantra Pharma Inc., acquires 100% of Cutimed Inc.'s shares for a total consideration of CAD $ 5.05 million.
- Cutimed Inc. is a Canadian company specializing in cosmetics and personal care products, including dermatological creams and cleanser products.
- The acquisition will strengthen Emcure's position in the Canadian dermatological and cosmetic product segments.
- The transaction is aligned with Emcure's core business and is subject to customary conditions and applicable laws in Canada.
- Cutimed Inc. has been operating in the Canadian market since 2011, focusing on the development and commercialization of cosmetic and dermatological products.
Price Impact